Strategy of liver-directed gene therapy: present status and future prospects

Area of Science:

• Hepatology
• Molecular Biology
• Gene Therapy

Background:

• The liver is a primary site for metabolic diseases and malignancies, making it a key target for gene therapy.
• Liver-directed gene therapy is actively developed to treat various liver conditions.

Purpose of the Study:

• To review strategies and key factors for successful liver-directed gene therapy.
• To explore methods for overcoming challenges in gene delivery, expression, and regulation.

Main Methods:

• Review of current liver-directed gene therapy strategies including drug delivery, gene compensation, anti-tumor, anti-viral, and immunomodulation.
• Discussion of critical success factors: gene intervention, delivery systems, stable/regulated expression, transfection, and timing.
• Exploration of tactics to overcome challenges: gene switches, transcriptional targeting, immune response circumvention, and engineered antibodies.

Main Results:

• The choice of gene therapy strategy depends on the specific genetic basis of the liver disease.
• Efficient gene delivery, stable and regulated transgene expression, successful target cell transfection, and appropriate timing are crucial.
• Techniques like gene switches and adenovirus vectors show potential for long-term correction and overcoming immune responses.

Conclusions:

• Liver-directed gene therapy encompasses diverse strategies tailored to specific genetic liver diseases.
• Overcoming challenges in gene delivery, expression, and immune response is vital for therapeutic success.
• Advancements suggest gene therapy may soon surpass conventional treatments for certain liver diseases.